To investigate the role of SIX4 in the development of CAC in a mouse model induced by AOM/DSS, in vivo-optimized si-NC and si-SIX4 were used to treat the CAC mouse model (Figure 2C, 2G). This evidence concerns the gene SIX4 and infectious otitis media.